A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
Clinical trial NCT05071664 · COMPLETED
Trial details
- NCT number
- NCT05071664
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2024-05-14
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.